Risk factors for KPC-producing Klebsiella pneumoniae bacteremia

Brazilian Journal of Infectious Diseases

Volumn 16, Issue 5, 2012, Pages 416-419

  Tuon, Felipe F ^a,b   Rocha, Jaime L ^c   Toledo, Paula ^b,d   Arend, Lavinia N ^e   Dias, Camila H ^a   Leite, Talita M ^a   Penteado Filho, Sergio R ^a   Pilonetto, Marcelo ^e   Zavascki, Alexandre P ^f  

^a HOSPITAL UNIVERSITÁRIO EVANGÉLICO DE CURITIBA   (Brazil)

^b STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

^c Division of Microbiology   (Brazil)

^d Centro de Epidemiologia da Secretaria Municipal de Saúde de Curitiba   (Brazil)

^e Paraná s Central Laboratory LACEN PR   (Brazil)

^f HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Bacteremia risk factors; Carbapenems; Klebsiella pneumoniae; Klebsiella pneumoniae carbapenemases

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; INFECTION RISK; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED;

EID: 84866861404     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.08.006     Document Type: Article

References (11)

1. Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
2. Nordmann P., Cuzon G., Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009, 9:228-236.
3. Mouloudi E., Protonotariou E., Zagorianou A., et al. Bloodstream infections caused by metallo-beta-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 2010, 31:1250-1256.
4. Gasink L.B., Edelstein P.H., Lautenbach E., Synnestvedt M., Fishman N.O. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009, 30:1180-1185.
5. Kang C.I., Kim S.H., Park W.B., et al. Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa. Microb Drug Resist 2005, 11:68-74.
6. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, Pennsylvania. Clinical and Laboratory Standards Institute 2010, CLSI.
7. Trevino M., Navarro D., Barbeito G., Garcia-Riestra C., Crespo C., Regueiro B.J. Molecular and epidemiological analysis of nosocomial carbapenem-resistant Klebsiella spp. using repetitive extragenic palindromic-polymerase chain reaction and matrix-assisted laser desorption/ionization-time of flight. Microb Drug Resist 2011, 17:433-442.
8. Chen L., Mediavilla J.R., Endimiani A., et al. Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (bla KPC) variants. J Clin Microbiol 2011, 49:579-585.
9. Kitchel B., Rasheed J.K., Patel J.B., et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009, 53:3365-3370.
10. Mendes R.E., Bell J.M., Turnidge J.D., et al. Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene. Antimicrob Agents Chemother 2008, 52:798-799.
11. D'Agata E.M. Methodologic issues of case-control studies: a review of established and newly recognized limitations. Infect Control Hosp Epidemiol 2005, 26:338-341.